Marcus Daly Memorial Hospital Corporation
Marcus Daly Memorial Hospital Corporation was paid $4.41M by Medicaid between Jan 2018 and Dec 2024, across 187 billing codes. Its largest line is 99284, emergency room visit (serious) — 28% of everything it billed.
HAMILTON, MT 59840
Next to other Critical Access Hospital providers in Montana
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 61,161 | $605K | |
| 2019 | 62,259 | $594K | |
| 2020 | 56,637 | $501K | |
| 2021 | 72,073 | $681K | |
| 2022 | 74,589 | $772K | |
| 2023 | 72,299 | $731K | |
| 2024incomplete | 50,925 | $524K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 28% | 21,118 | 17,258 | $1.24M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 22% | 23,342 | 20,617 | $975K |
| A0427 | Emergency ambulance ride, advanced life supportAmbulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) | 5.9% | 2,498 | 1,839 | $260K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 5.5% | 18,578 | 5,747 | $242K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 5.3% | 3,925 | 3,510 | $235K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 3.8% | 17,856 | 5,187 | $167K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 3.7% | 6,495 | 4,688 | $162K |
| A0429 | Emergency ambulance ride, basic life supportAmbulance service, basic life support, emergency transport (bls-emergency) | 3.2% | 1,993 | 1,411 | $143K |
| A0390 | Als mileage (per mile) | 2.9% | 1,403 | 1,124 | $126K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 1.8% | 4,139 | 3,744 | $81K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.7% | 3,767 | 3,419 | $74K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.3% | 2,587 | 2,298 | $56K |
175 more codes
| G0378 | Hospital observation service, per hour | <1% | 1,739 | $37K |
| 80053 | Comprehensive metabolic panel | <1% | 25,952 | $33K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 15,896 | $33K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 3,445 | $30K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 7,758 | $27K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 3,386 | $25K |
| 71045 | Radiologic examination, chest; single view | <1% | 6,139 | $25K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 29,691 | $22K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 510 | $20K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 4,394 | $19K |
| A0426 | Ambulance service, advanced life support, non-emergency transport, level 1 (als 1) | <1% | 172 | $16K |
| A0380 | Bls mileage (per mile) | <1% | 196 | $14K |
| 73110 | <1% | 1,254 | $14K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 503 | $14K |
| A0425 | Ground mileage, per statute mile | <1% | 2,914 | $14K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 4,532 | $13K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 6,906 | $13K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 9,429 | $12K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 4,670 | $11K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 2,746 | $11K |
| 73630 | <1% | 1,357 | $10K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,354 | $10K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 1,137 | $9K |
| 73610 | <1% | 1,104 | $9K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 3,100 | $9K |
| 81025 | <1% | 4,153 | $8K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 1,134 | $8K |
| 36415 | Collection of venous blood by venipuncture | <1% | 30,021 | $7K |
| 73130 | <1% | 1,004 | $7K | |
| 80306 | <1% | 3,048 | $7K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 5,591 | $6K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 5,926 | $6K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,560 | $6K |
| 81001 | <1% | 7,273 | $6K | |
| 87040 | <1% | 2,698 | $6K | |
| 83690 | <1% | 6,003 | $6K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 2,433 | $5K |
| 73564 | <1% | 789 | $5K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 545 | $5K |
| 80143 | <1% | 863 | $5K | |
| 81003 | <1% | 6,452 | $5K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 919 | $4K |
| 73030 | <1% | 1,156 | $4K | |
| 86140 | <1% | 3,989 | $4K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 3,045 | $4K |
| 80179 | <1% | 800 | $4K | |
| 87420 | <1% | 361 | $4K | |
| 94760 | <1% | 3,100 | $3K | |
| 87428 | <1% | 775 | $3K | |
| 87186 | <1% | 2,985 | $3K | |
| 84484 | <1% | 7,557 | $3K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 812 | $3K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 5,362 | $2K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 4,029 | $2K |
| 97161 | <1% | 719 | $2K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 2,186 | $2K |
| 85378 | <1% | 2,491 | $2K | |
| 72100 | <1% | 784 | $2K | |
| 87081 | <1% | 1,722 | $2K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 2,265 | $2K |
| 76830 | Ultrasound, transvaginal | <1% | 902 | $2K |
| 84145 | <1% | 1,351 | $2K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 6,905 | $2K |
| 96376 | <1% | 2,396 | $2K | |
| 97162 | <1% | 862 | $2K | |
| 83605 | <1% | 2,833 | $2K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 983 | $2K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 980 | $2K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 734 | $2K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 56 | $1K |
| 73140 | <1% | 90 | $1K | |
| 80061 | Lipid panel | <1% | 5,128 | $1K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 135 | $1K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,655 | $1K |
| 82948 | <1% | 3,069 | $1K | |
| 85651 | <1% | 1,879 | $1K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 1,151 | $1K |
| 72040 | <1% | 220 | $1K | |
| 59025 | Fetal non-stress test | <1% | 272 | $967.85 |
| 87070 | <1% | 824 | $952.31 | |
| 83735 | <1% | 2,683 | $859.04 | |
| 84439 | <1% | 1,939 | $840.26 | |
| 87088 | <1% | 1,926 | $824.72 | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 53 | $772.99 |
| 82728 | <1% | 1,110 | $761.41 | |
| 84703 | <1% | 576 | $754.83 | |
| 84702 | <1% | 543 | $687.40 | |
| 85610 | <1% | 3,624 | $674.89 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 4,092 | $666.44 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 58 | $646.38 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 392 | $633.45 |
| 73502 | <1% | 78 | $628.47 | |
| 87147 | <1% | 663 | $561.70 | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 14 | $553.40 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 129 | $539.97 |
| 97113 | <1% | 584 | $534.44 | |
| 83880 | <1% | 1,854 | $479.89 | |
| 82607 | <1% | 1,284 | $479.74 | |
| 72141 | <1% | 124 | $378.69 | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 116 | $358.61 |
| 85027 | <1% | 232 | $354.83 | |
| Q3014 | Telehealth originating site facility fee | <1% | 287 | $346.45 |
| 82805 | <1% | 91 | $346.07 | |
| 86308 | <1% | 97 | $312.67 | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 763 | $312.54 |
| 87077 | <1% | 329 | $297.20 | |
| 85007 | <1% | 122 | $286.43 | |
| 87210 | <1% | 368 | $286.03 | |
| 73080 | <1% | 47 | $262.35 | |
| 74018 | <1% | 33 | $238.50 | |
| 96367 | <1% | 82 | $206.74 | |
| 84100 | <1% | 534 | $206.46 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 2,436 | $188.39 |
| 86850 | <1% | 236 | $160.28 | |
| 86803 | <1% | 666 | $152.09 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 380 | $144.34 |
| 93320 | <1% | 77 | $107.34 | |
| 93350 | <1% | 77 | $107.22 | |
| 83540 | <1% | 632 | $103.36 | |
| 84466 | <1% | 451 | $102.00 | |
| 87493 | <1% | 32 | $92.99 | |
| 86901 | <1% | 313 | $91.58 | |
| 93325 | <1% | 77 | $90.15 | |
| 86900 | <1% | 295 | $89.69 | |
| 87045 | <1% | 100 | $87.78 | |
| 93017 | <1% | 65 | $85.29 | |
| 82272 | <1% | 92 | $77.10 | |
| 73562 | <1% | 15 | $65.62 | |
| 85730 | <1% | 787 | $64.38 | |
| A9270 | Non-covered item or service | <1% | 4,284 | $53.95 |
| 86592 | <1% | 478 | $45.39 | |
| 99217 | <1% | 31 | $42.96 | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 1,350 | $23.98 |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 323 | $15.92 |
| 82550 | <1% | 138 | $12.91 | |
| 86703 | <1% | 308 | $9.59 | |
| 12002 | <1% | 13 | $0.01 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 0% | 13 | $0.00 |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 0% | 155 | $0.00 |
| 82150 | 0% | 24 | $0.00 | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 0% | 442 | $0.00 |
| 20610 | 0% | 25 | $0.00 | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 0% | 1,956 | $0.00 |
| 77063 | Screening digital breast tomosynthesis, bilateral | 0% | 675 | $0.00 |
| 97166 | 0% | 50 | $0.00 | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 0% | 49 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 35 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 13 | $0.00 |
| 87340 | 0% | 13 | $0.00 | |
| 80069 | 0% | 14 | $0.00 | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 0% | 12 | $0.00 |
| 72170 | 0% | 12 | $0.00 | |
| 70496 | 0% | 26 | $0.00 | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | 0% | 54 | $0.00 |
| 93971 | 0% | 86 | $0.00 | |
| 12001 | 0% | 14 | $0.00 | |
| 84153 | 0% | 17 | $0.00 | |
| 80055 | 0% | 15 | $0.00 | |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 31 | $0.00 |
| 70498 | 0% | 15 | $0.00 | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 0% | 861 | $0.00 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 0% | 566 | $0.00 |
| 92015 | Determination of refractive state | 0% | 66 | $0.00 |
| 99215 | Doctor's office visit, returning patient (complex) | 0% | 944 | $0.00 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 0% | 33 | $0.00 |
| 87328 | 0% | 12 | $0.00 | |
| 99204 | Doctor's office visit, new patient (more involved) | 0% | 92 | $0.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 59 | $0.00 |
| 80305 | 0% | 31 | $0.00 | |
| 84481 | 0% | 27 | $0.00 | |
| 71250 | 0% | 13 | $0.00 | |
| 87329 | 0% | 12 | $0.00 | |
| 80164 | 0% | 13 | $0.00 | |
| 82570 | 0% | 12 | $0.00 | |
| 83630 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Marcus Daly Memorial Hospital Corporation | Hamilton, MT | $209K |
| Marcus Daly Memorial Hospital Corp | Hamilton, MT | $39K |
| Marcus Daly Memorial Hospital Corp | Hamilton, MT | $38K |
| Marcus Daly Memorial Hospital Corporation | Darby, MT | $17K |
| Marcus Daly Memorial Hospital Corporation | Victor, MT | $15K |
| Marcus Daly Memorial Hospital Corporation | Hamilton, MT | $14K |
| Marcus Daly Memorial Hospital Corporation | Hamilton, MT | $9K |
| Marcus Daly Memorial Hospital Corp | Hamilton, MT | $4K |
| Marcus Daly Memorial Hospital Corporation | Hamilton, MT | $790.52 |
| Marcus Daly Memorial Hospital Corporation | Stevensville, MT | $267.83 |
| Marcus Daly Memorial Hospital Corporation | Corvallis, MT | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.